Early Diagnosis of Tularemia by Flow Cytometry, Czech Republic, 2003–2015
暂无分享,去创建一个
N. Beeching | A. Semper | V. Chmelík | O. Dvořáčková | A. Chrdle | Pavlína Tinavská | P. Filipová | Věra Hnetilová | P. Žampach | Květoslava Batistová
[1] Ö. Terzi,et al. Predicting tularemia with clinical, laboratory and demographical findings in the ED. , 2016, The American journal of emergency medicine.
[2] D. Yıldırım,et al. Evaluation of tularaemia courses: a multicentre study from Turkey. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[3] I. Bank,et al. Quantitative Peripheral Blood Perturbations of γδ T Cells in Human Disease and Their Clinical Implications , 2014, Clinical Reviews in Allergy & Immunology.
[4] V. Vaillant,et al. 10 years of surveillance of human tularaemia in France. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[5] Eli Schwartz,et al. Gamma delta T cells in non-immune patients during primary schistosomal infection , 2014, Immunity, inflammation and disease.
[6] B. Onal,et al. Tularemia: potential role of cytopathology in differential diagnosis of cervical lymphadenitis: Multicenter experience in 53 cases and literature review , 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[7] W. Weichert,et al. Unmasked: when a clinically malignant disease turns out infectious. A rare case of tularemia. , 2013, International journal of surgical pathology.
[8] P. Mead,et al. Clinical recognition and management of tularemia in Missouri: a retrospective records review of 121 cases. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] J. Brion,et al. Human tularemia in France, 2006-2010. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] M. Tan,et al. Impact of age, gender, and race on circulating γδ T cells. , 2010, Human immunology.
[11] H. Akbulut,et al. Gamma/delta T cells in patients with acute brucellosis , 2009, Clinical and Experimental Medicine.
[12] A. Sjöstedt. Tularemia: History, Epidemiology, Pathogen Physiology, and Clinical Manifestations , 2007, Annals of the New York Academy of Sciences.
[13] N. Letvin,et al. Vγ2Vδ2+ T cells and anti-microbial immune responses , 2003 .
[14] E. Bäck,et al. An outbreak of primary pneumonic tularemia. , 2002, The New England journal of medicine.
[15] A. Tärnvik,et al. Vγ9Vδ2 T Cells in Human Legionellosis , 2001, Clinical Diagnostic Laboratory Immunology.
[16] J. Pérez-Castrillón,et al. Tularemia epidemic in northwestern Spain: clinical description and therapeutic response. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] A. Lim,et al. High frequency of circulating γδ T cells with dominance of the Vδ1 subset in a healthy population , 2000 .
[18] A. Tärnvik,et al. The proportion of circulating γδ T cells increases after the first week of onset of tularaemia and remains elevated for more than a year , 2000 .
[19] A. Sjöstedt,et al. Expansion of Vγ9Vδ2 T Cells Is Triggered byFrancisella tularensis-Derived Phosphoantigens in Tularemia but Not after Tularemia Vaccination , 1998, Infection and Immunity.
[20] M. Zeitz,et al. The Number and Proportion of Vϒ9Vδ2 T Cells Rise Significantly in the Peripheral Blood of Patients After the Onset of Acute Coxiella burnetii Infection , 1997 .
[21] J. Grunewald,et al. Different Percentages of Peripheral Blood γδ+ T Cells in Healthy Individuals from Different Areas of the World , 1996 .
[22] C. Caldwell,et al. Lymphocytosis of γ/δ T Cells in Human Ehrlichiosis , 1995 .
[23] W. Boom,et al. CD4+ alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production. , 1995, Journal of immunology.
[24] P. Kragsbjerg,et al. Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and streptococci using a seminested PCR strategy , 1994, Journal of clinical microbiology.
[25] K. Mendis,et al. Transient increase in circulating gamma/delta T cells during Plasmodium vivax malarial paroxysms , 1994, The Journal of experimental medicine.
[26] S. Reed,et al. Antigen-reactive gamma delta T cells in human leishmaniasis. , 1993, Journal of Immunology.
[27] R. Gerli,et al. Lymphocytes bearing the γδ T cell receptor in acute Brucella melitensis infection , 1993 .
[28] R. Gerli,et al. Lymphocytes bearing the gamma delta T-cell receptor in acute toxoplasmosis. , 1992, Immunology.
[29] H. Takada,et al. Predominant activation and expansion of V gamma 9-bearing gamma delta T cells in vivo as well as in vitro in Salmonella infection. , 1992, The Journal of clinical investigation.
[30] T. Sumida,et al. Predominant expansion of V gamma 9/V delta 2 T cells in a tularemia patient , 1992, Infection and immunity.
[31] M. Maurin,et al. Tularaemia: clinical aspects in Europe. , 2016, The Lancet. Infectious diseases.
[32] I. Selingerová,et al. [Immunological Aspects in Oncology--Circulating γδ T Cells]. , 2015, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.
[33] R. Evans. European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[34] Z. Černý. Changes of the epidemiology and the clinical picture of tularemia in Southern Moravia (the Czech Republic) during the period 1936–1999 , 2004, European Journal of Epidemiology.
[35] J. Pérez-Castrillón,et al. An outbreak of primary pneumonic tularemia. , 2002, New England Journal of Medicine.
[36] W. Youden,et al. Index for rating diagnostic tests , 1950, Cancer.
[37] G. Mccoy,et al. Further Observations on a Plague-Like Disease of Rodents with a Preliminary Note on the Causative Agent, Bacterium Tularense , 1912 .